C-ABDDBE Therapeutics
stem cell-derived tissue, biomaterials, CNS regeneration
replacementreplacingtissue engineered
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-ABDD
C-ABDDC-ABDDstem cell-derived tissue, biomaterials, CNS regeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
BE Therapeutics states that permanent central nervous system damage from stroke, trauma, neurodegeneration, and aging can be reversed by engineering stem cell-derived replacement tissue. The company says its approach is to build precursor brain tissue modeled on normal early neurodevelopment, with the right cell types, signaling cues, and structure so that after transplantation the tissue can mature normally, integrate with the host, and encode useful information, with an initial focus on replacing damaged neocortical tissue.
SourceBE Therapeutics states that permanent damage to the central nervous system from stroke, trauma, neurodegeneration, and aging is not currently reversible with existing treatments, and that engineered functional brain and spinal cord tissue can serve as replacement tissue to restore lost function and counter age-related and other forms of CNS damage in order to ensure indefinite function.
SourceBE Therapeutics states that permanent damage to the central nervous system from stroke, trauma, neurodegeneration, and aging can be addressed by engineering functional replacement tissue. The company believes patient-beneficial tissue can be built by mimicking embryonic brain development, creating precursor tissue with the right cell types, signaling cues, and structure so it can mature after transplantation, integrate with the host, and restore useful function.
Source